Is a complete BIT/FDA research report available?

No complete published report is available for bit/FDA (BIT/FDA) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

bit/FDA stock profile: metrics, valuation and analysis

Market cap	3.9M
Revenue (ttm)	30.6M
Net income (ttm)	1M
EPS (ttm)	€0.00
Shares out	499.4M
P/E (trailing)	2.6x
Volume	19,304,655
Beta	0.36

All BIT/FDA indicators

Market & fundamental data

Available fields

209

Groups with data

Currency

EUR

Showing 209 of 209 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Italy
Country code	IT
Employees	146
Employees Change	-13%
Employees Change Percent	-8.18
Enterprise value	EUR 7.4M
Exchange	Borsa Italiana
Financial currency	EUR
First seen	2026-05-10
Industry	Specialty Industrial Machinery
Industry PE	18.54
Industry PE Fwd	13.34
Isin	IT0005654683
Last refreshed	2026-09-06
Market cap	EUR 3.9M
Price	EUR 0.01
Price currency	EUR
Rev Per Employee	209,328.77x
Sector	Industrials
Sector PE	16.86
Sector PE Fwd	16.17
Sic	3540
Symbol	bit/FDA
Website	https://www.fidia.it

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	26.67%
EV Earnings	7.14x
EV/Sales	0.24x
FCF yield	-95.29%
P/B ratio	0.48x
P/E ratio	2.6x
P/S ratio	0.13x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-5.6%
EBITDA Margin	-5.12%
Gross margin	62.4%
Gross Profit	EUR 19.1M
Gross Profit Growth	46.51%
Gross Profit Growth Q	80.57%
Gross Profit Growth3 Y	8.12%
Gross Profit Growth5 Y	-11.41%
Net Income	EUR 1M
Net Income Growth Quarters	6%
Net Income Growth Years	1%
Net Income Growth3 Y	-44.16%
Pretax Margin	4.03%
Profit Margin	3.4%
Profit Per Employee	EUR 7,116
Profitable Quarters	EUR 2
Profitable Years	1
ROA	-3.92
Roa5y	-6.28
ROCE	-13.08
ROE	18.29
ROIC	-12.06
Roic5y	-33.61

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-67.23%
Cagr15y	-50.22%
Cagr1y	-97.34%
Cagr20y	-41.71%
Cagr3y	-95.99%
Cagr5y	-87.38%
Div CAGR10	3.63%
Div CAGR3	-7.17%
Div CAGR5	-4.36%
EPS Growth Quarters	6
EPS Growth Years	1
EPS Growth3 Y	-96.73
Revenue Growth	74.3x
Revenue Growth Q	125.04x
Revenue Growth Qo Q	24.94x
Revenue Growth Quarters	4x
Revenue Growth Years	1x
Revenue Growth3 Y	7.41x
Revenue Growth5 Y	-12.94x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 1.12
Assets	EUR 26.3M
Cash	EUR 2.4M
Current Assets	EUR 17.3M
Current Liabilities	EUR 13.3M
Debt	EUR 6M
Debt Equity	EUR 0.74
Debt FCF	EUR -1.61
Equity	EUR 8.1M
Interest Coverage	-5.42
Liabilities	EUR 18.3M
Long Term Assets	EUR 9.1M
Long Term Liabilities	EUR 5M
Net Cash	EUR -3.5M
Net Cash By Market Cap	EUR -90.85
Net Debt Equity	EUR 0.44
Tangible Book Value	EUR 7.7M
Tangible Book Value Per Share	EUR 0.26
WACC	5.08

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.3
Inventory Turnover	1.2
Net Working Capital	EUR 3.5M
Quick ratio	0.71
Working Capital	EUR 4M
Working Capital Turnover	EUR -177

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-122,259.38%
Dividend per share	EUR 0
Last Dividend	EUR 20

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-100%
1Y total return	-97.34%
200-day SMA	0.05
3Y total return	-99.99%
50-day SMA	0.01
50-day SMA vs 200-day SMA	50under200
5Y total return	-100%
All Time High	2,037
All Time High Change	-100%
All Time High Date	2007-03-15
All Time Low	0
All Time Low Change	160%
All Time Low Date	2026-05-14
ATR	0
Beta	0.36
Beta1y	1.97
Beta2y	2.67
Ch YTD	-93.54
High	0.01
High52	0.31
High52 Date	2025-09-30
High52ch	-97.44%
Low	0.01
Low52	0
Low52 Date	2026-05-15
Low52ch	160%
Ma50ch	-9.3%
Price vs 200-day SMA	-85%
RSI	47.41
RSI Monthly	25.22
RSI Weekly	25.14
Sharpe ratio	-0.81x
Sharpe Ratio3y	-1.16x
Sharpe Ratio5y	-0.95x
Sortino ratio	-1.77
Sortino Ratio3y	-2.12
Sortino Ratio5y	-1.7
Total Return	-122,259.38%
Tr YTD	-93.54
Tr15y	-100%
Tr1m	-15.22%
Tr1w	2.63%
Tr3m	62.5%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	497,410,965%
Net Borrowing	4,551,000
Shares Institutions	-1.44%
Shares Out	499,411,971
Shares Qo Q	19,688.38%
Shares Yo Y	122,259.38%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	6,280,713.3x
Bv Per Share	0.27
CAPEX	EUR -425,000
Ch10y	-100
Ch15y	-100
Ch1m	-15.22
Ch1w	2.63
Ch1y	-97.34
Ch20y	-100
Ch3m	62.5
Ch3y	-99.99
Ch5y	-100
Ch6m	-86.78
Change	18.18%
Change From Open	14.71
Close	0.01
Days Gap	3.03
Depreciation Amortization	148,000
Dollar Volume	150,576.3
Earnings Date	2026-09-11
EBIT	EUR -1.7M
EBITDA	EUR -1.6M
EPS	EUR 0
F Score	3
FCF	EUR -3.7M
FCF EV Yield	-50x
FCF Per Share	EUR -0.01
Financing CF	4,207,000
Fiscal Year End	December
Founded	1,974
Graham Number	0.13408
Graham Upside	1,619
Income Tax	EUR 226,000
Investing CF	648,000
Is Primary Listing	1
Last Earnings Date	2025-11-14
Last Report Date	2025-12-31
Last Split Date	2025-06-16
Last Split Type	Reverse
Lynch Fair Value	EUR 0.02
Lynch Upside	92.31
Ma150	0.02
Ma150ch	-68.42%
Ma20	0.01
Ma20ch	0%
Net CF	1,134,000
Next Earnings Date	2026-09-11
Open	0.01
Position In Range	100
Ppne	7,491,000
Price Date	2026-09-04
Ptbv Ratio	0.5
Relative Volume	3.51x
Revenue	30,562,000x
Tax By Revenue	0.74x
Tax Rate	18.33%
Tr20y	-100%
Tr6m	-86.78%
Volume	19,304,655

BIT/FDA (BIT/FDA)

Price

Financial snapshot

Fair-value bridge

Latest news · BIT/FDA

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BIT/FDA indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Other indicators

Deeper analysis on BIT/FDA

Frequently asked questions